Champions Oncology appoints Philip Breitfeld to board
Article continues below
Dr. Breitfeld has more than 30 years of experience in oncology. He was most recently Global Vice President at Quintiles, responsible for the Therapeutic Centers of Excellence. Prior to that, he led the Oncology Center of Excellence at Quintiles.
Dr. Breitfeld held senior clinical development positions at Merck KGaA (EMD Serono in the U.S.), where he led oncology development in the US, and at BioCryst, where he led oncology development and was Associate Chief Medical Officer.
Prior to his career in industry, Dr. Breitfeld held academic positions at Harvard, University of Massachusetts, Indiana University, and Duke. He has approximately 50 publications in the literature. ■